ARTICLE | Company News
UCB sells U.S. generics unit to Lannett
September 4, 2015 1:08 AM UTC
UCB Group (Euronext:UCB) is selling U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett Co. Inc. (NYSE:LCI) for $1.2 billion in cash. The parties expect the deal to close in 4Q15. L...